NTNU – Norwegian University of Science and Technology

Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

4,351 to 4,360 of 8,623 Results

02_NINA-1_IB_version_7_March2020.pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 1.1 MB - MD5: b7b54792d295074da50ddc8a6c820739 INVESTIGATOR’S BROCHURE PRODUCT: Nalokson DnE Nasal Spray 14 mg/mL
03_1_NINA-1_informed_consent_forms .pdf Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 2.9 MB - MD5: fadb8e879384d400b763ccb91a4e3b04 Example informed consent information forms from study kit and online version
04_1_NINA-1_Annual_Safety_Report_NoMA_2018_19.pdf Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 1.1 MB - MD5: 22f771682f3dc9ea8e914a86bd00dd01 Annual Safety reports submitted to Norwegian Medicines Agency
04_2_NINA-1_Data_monitoring_committee_reports .pdf Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 341.8 KB - MD5: 6b5a9190b6ecd5a3da166b583b2a11ff
04_3_NINA-1_Data_monitoring_committee_charter .pdf Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 219.4 KB - MD5: d725d4e3dbba6ad4e314b3ddaabfba73
05_1_NINA-1_ Insurance_statements.pdf Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 197.6 KB - MD5: 81e4852c8359b45635a636985d648d45
05_3_NINA-1_Financing_Contract_NTNU_FarmaIndusriAS.pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 971.7 KB - MD5: 3448326f647098679153a61679819f99 Agreements between NTNU and Farma Industri governing the funding of Study Medicine and ensuring NTNU full ownership of trial results.
05_3_NINA-1_Financing_Regional_Health_Authority(EN_NO).pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 3.3 MB - MD5: a95cf2d72d1dfc324e125ab8dcba0430 Financing for PhD position for Arne Skulberg supervised by Prof. Ola Dale and main funding for NINA-1
06_1_NINA-1_National_Ethics_Approval_March_2017_(EN_NO).pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 7.8 MB - MD5: ea3a92eae5a70cf98e2cfe42711db753 Trial approval and review by The National Committee for Medical and Health Research Ethics (NEM) in Norway
06_1_NINA-1_Regional_Ethics_Approval_March_2020(EN_NO).pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 1.0 MB - MD5: b30e40d8eb4857663520f6a8324ea060 Approval of protocol version 3.3 06. March 2020 by The Regional Committee for Medical and Health Research Ethics (REC) in Norway

02_NINA-1_IB_version_7_March2020.pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 1.1 MB -

INVESTIGATOR’S BROCHURE PRODUCT: Nalokson DnE Nasal Spray 14 mg/mL

03_1_NINA-1_informed_consent_forms .pdf

Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 2.9 MB -

Example informed consent information forms from study kit and online version

04_1_NINA-1_Annual_Safety_Report_NoMA_2018_19.pdf

Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 1.1 MB -

Annual Safety reports submitted to Norwegian Medicines Agency

04_2_NINA-1_Data_monitoring_committee_reports .pdf

Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 341.8 KB -

04_3_NINA-1_Data_monitoring_committee_charter .pdf

Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 219.4 KB -

05_1_NINA-1_ Insurance_statements.pdf

Jan 22, 2021 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 197.6 KB -

05_3_NINA-1_Financing_Contract_NTNU_FarmaIndusriAS.pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 971.7 KB -

Agreements between NTNU and Farma Industri governing the funding of Study Medicine and ensuring NTNU full ownership of trial results.

05_3_NINA-1_Financing_Regional_Health_Authority(EN_NO).pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 3.3 MB -

Financing for PhD position for Arne Skulberg supervised by Prof. Ola Dale and main funding for NINA-1

06_1_NINA-1_National_Ethics_Approval_March_2017_(EN_NO).pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 7.8 MB -

Trial approval and review by The National Committee for Medical and Health Research Ethics (NEM) in Norway

06_1_NINA-1_Regional_Ethics_Approval_March_2020(EN_NO).pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 1.0 MB -

Approval of protocol version 3.3 06. March 2020 by The Regional Committee for Medical and Health Research Ethics (REC) in Norway

Add Data

Share Dataverse

Link Dataverse

Reset Modifications